Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
$0.37
-5.1%
$0.57
$0.29
$1.65
$30.42M2.08510,238 shs1.52 million shs
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
$2.75
-9.8%
$2.73
$1.20
$17.75
$4.27M0.1378,983 shs178,206 shs
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
$1.40
-2.8%
$1.35
$0.81
$1.82
$76.31M1.52304,026 shs1.15 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
-5.14%-9.75%-18.33%-51.64%-63.25%
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
-9.84%-15.38%-0.72%+13.17%-81.73%
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
-2.78%-5.41%-1.41%+61.66%-11.95%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
2.4591 of 5 stars
4.13.00.00.02.90.00.0
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
2.4461 of 5 stars
3.52.00.00.02.71.70.6
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
3.102 of 5 stars
3.53.00.00.03.32.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
2.17
Hold$4.201,042.86% Upside
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
3.00
Buy$10.00263.64% Upside
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
3.00
Buy$5.50292.86% Upside

Current Analyst Ratings Breakdown

Latest EVAX, PMVP, and CLSD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/18/2025
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$5.00
7/18/2025
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
7/18/2025
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$2.00
7/17/2025
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/17/2025
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeModerate Buy ➝ Hold$3.00
(Data available from 8/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
$1.66M17.38N/AN/A($0.62) per share-0.59
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
$3.34M1.15N/AN/A$4.44 per share0.62
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
N/AN/AN/AN/A$2.65 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
-$34.35M-$0.37N/AN/AN/A-665.19%N/A-124.15%11/11/2025 (Estimated)
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
-$10.57M-$1.32N/AN/AN/A-316.03%-319.52%-63.56%10/30/2025 (Estimated)
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
-$58.71M-$1.57N/AN/AN/AN/A-47.94%-43.82%11/6/2025 (Estimated)

Latest EVAX, PMVP, and CLSD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
-$0.50-$0.76-$0.26-$0.76N/A$0.04 million
8/8/2025Q2 2025
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
-$0.12-$0.06+$0.06-$0.06$0.50 million$0.49 million
8/7/2025Q2 2025
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
-$0.39-$0.41-$0.02-$0.41N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
N/AN/AN/AN/AN/A
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
N/AN/AN/AN/AN/A
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
N/A
3.87
3.87
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
1.73
3.42
3.42
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
N/A
12.52
12.52

Institutional Ownership

CompanyInstitutional Ownership
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
18.75%
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
11.04%
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
90.20%

Insider Ownership

CompanyInsider Ownership
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
6.70%
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
41.64%
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
7.57%
CompanyEmployeesShares OutstandingFree FloatOptionable
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
3078.51 million73.25 millionOptionable
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
601.40 million819,000No Data
PMV Pharmaceuticals, Inc. stock logo
PMVP
PMV Pharmaceuticals
5052.99 million48.98 millionOptionable

Recent News About These Companies

Pmv Pharmaceuticals Inc (PMVP) - Investing.com
PMV Pharmaceuticals reports FY24 EPS ($1.14), consensus ($1.02)
PMV Pharmaceuticals sees cash runway to end of 2026
PMV Pharmaceuticals files $200M mixed securities shelf
PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results
PMV Pharmaceuticals (PMVP) Gets a Buy from Craig-Hallum

New MarketBeat Followers Over Time

Media Sentiment Over Time

Clearside Biomedical stock logo

Clearside Biomedical NASDAQ:CLSD

$0.37 -0.02 (-5.14%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$0.37 +0.00 (+0.14%)
As of 08/29/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Evaxion A/S stock logo

Evaxion A/S NASDAQ:EVAX

$2.75 -0.30 (-9.84%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$2.80 +0.04 (+1.64%)
As of 08/29/2025 06:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based vaccine that is in Phase 1/2a trial designed to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers. Its programs also include some vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, viral vaccine product candidate for targeting Cytomegalovirus. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.

PMV Pharmaceuticals stock logo

PMV Pharmaceuticals NASDAQ:PMVP

$1.40 -0.04 (-2.78%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.41 +0.01 (+0.71%)
As of 08/29/2025 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.